The Scripps Research Institute (TSRI) announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus. Under the agreement Janssen will receive certain license rights to the results of the research. Janssen Pharmaceuticals will collaborate in the research on influenza through its Crucell Vaccine Institute. The new agreement builds on research on the influenza virus conducted jointly by TSRI and Janssen’s Crucell Vaccine Institute.

Full media release: http://www.prnewswire.com/news-releases/the-scripps-research-institute-announces-new-research-and-license-agreement-with-janssen-pharmaceuticals-inc-206392741.html